Scholars Central

Conference abstractPublished 2017

Engineered nanomaterials: Toward effective safety management in research laboratories

Authors: Thierry Meyer, Groso A

EPFL, Switzerland

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Evaluating the risk of a chemical substance to cause harm involves the compilation of accurate detailed information from all the available sources (SDS, toxicological information, etc.). However, engineered nanomaterials (ENMs) often demonstrate properties that differ from the ones of the same material in the bulk form, providing opportunities for new applications but also for new hazards. Given the current state of knowledge on ENMs, it is likely that several years will be needed before we will precisely know which types of ENMs and associated doses will represent a real danger to humans and the surrounding environment. In the meantime, there is a consensus on applying the precautionary principle to these novel materials until more information is available. One pragmatic way of applying it is to use a control banding approach for managing chemical risks in an effective manner. Nevertheless, the uncertainty on both exposure and impact as well as a cautionary approach seem to result in a high level of estimated risk requiring high protection. In research and teaching institutions, we face a highly versatile environment with large number of laboratories and large cohorts of inexperienced people (students), staff having a high level of education but with high turnover. We will present a practical and pragmatic implementation of a “Nano” safety management system based on a control banding method and 10 years’ experience. It is applied to over 120 research labs dealing with ENMs. This system is composed of: 1) ‘nano’ activity analysis allowing classifying the lab into a risk level and 2) the implementation of the adequate preventive and protective mitigation measures corresponding to the risk level. We will conclude by discussing the difficulties, the drawbacks and the success encountered in an evolving and rapidly changing environment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmaceutics & Drug Delivery Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutics & Drug Delivery Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Thierry Meyer”
  • BylineArticles whose byline prints “Groso A”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels